• Home
  • Company Profile
  • News
  • Products
  • Cart
  • Checkout
  • My Account
  • Terms & Conditions
  • Privacy Policy
Paragon BioTeck, Inc.Paragon BioTeck, Inc.
  • HOME
  • ABOUT
    • Company Profile
    • Business Integrity
  • PRODUCTS
    • Diagnostics
      • Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% 15 mL
      • Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% 10mL
      • Phenylephrine Hydrochloride Ophthalmic Solution USP 10% 5mL
  • NEWS
  • CONTACT
18 Apr
0

Paragon BioTeck, Inc., Adds Unique Perspective to Scientific Advisory Board

Scientific Advisory Board

SAN DIEGO, Calif. – Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, announced today that Captain Ed Woodward, former standout Air Force pilot and Tillman Military Scholar will be inducted as an honorary member of the company’s Scientific Advisory Board (SAB) at ASCRS. Woodward currently attends University of South Florida’s (USF) Morsani School of Medicine; he was medically retired from the Air Force after sustaining a traumatic brain injury (TBI) during inflight training.

Read More
17 Nov
0

Paragon BioTeck, Inc., Receives CE Mark Approval on Comfortear® Lacrisolve™ Absorbable Punctum Plug

Punctal Occlusion

PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear® Lacrisolve™ Absorbable Punctum Plug. CE mark approval is recognized and associated with safety and performance in multiple countries.

Read More
15 Oct
0

Paragon BioTeck, Inc., Announces Corporate Citizenship Initiative, ‘Paragon Gives’

Lacrisolve, Paragon Gives, Philanthropy, Press Release, Punctal Occlusion

PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic […]

Read More
25 Jun
0

Paragon BioTeck, Inc., Receives FDA Clearance for Comfortear® Lacrisolve™ Absorbable Punctum Plug

Lacrisolve, Press Release, Punctal Occlusion

PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, […]

Read More
09 Apr
0

Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% and 10% Readily Available

Phenylephrine, Press Release

PORTLAND, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, […]

Read More
08 Oct
0

Paragon BioTeck, Inc., Signs Exclusive Distribution Agreement with Horus Pharma for ilast®

Horus Pharma, ilast, Lid Hygiene, Press Release

PORTLAND, Ore. — Paragon BioTeck, Inc., today announced that it has signed a distribution agreement with Horus Pharma for rights […]

Read More
19 Apr
0

Paragon BioTeck, Inc., Signs Exclusive License Agreement with Bausch + Lomb for Phenylephrine

Bausch + Lomb, Phenylephrine, Press Release

Recent U.S FDA Approval of Paragon’s NDA Clears the Way for Bausch + Lomb Commercialization TIGARD, Ore. & MADISON, N.J. […]

Read More
21 Mar
0

Paragon BioTeck, Inc. Announces FDA Approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% & 10%

FDA Approval, Phenylephrine, Press Release

TIGARD, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, […]

Read More
13 Mar
0

Paragon BioTeck, Inc., Appoints New U.S. Medical Advisor

Press Release, Scientific Advisory Board

TIGARD, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, […]

Read More
15 Dec
0

Paragon BioTeck, Inc., Sponsors Event to Benefit Developmentally Disabled

Paragon Gives, Philanthropy, Sponsored Events

TIGARD, Ore. — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, […]

Read More
  • 1
  • 2
  • …
  • 5
  • 6
  • 7

RECENT POSTS

  • Paragon BioTeck Reformulated FRESHKOTE®, Prompting Eyevance Acquisition 09/14/2018
  • Paragon BioTeck, Inc. Hosts Pearl Buck Preschool Holiday Event 12/01/2017
  • Paragon BioTeck, Inc. Announces Call for 2018 Koch Kellan Scholarship Applicants 10/02/2017
  • Talking to Patients About Eye Health 08/24/2017
  • Xinxin Zhang shares her experience at ASCRS•ASOS 06/12/2017

Newsletter Sign-Up

  • This field is for validation purposes and should be left unchanged.

HOME

Contact Us
News

PRODUCTS

Diagnostics

ABOUT

Company Profile
Business Integrity

CUSTOMER SERVICE

1-888-424-1192
customercare@paragonbioteck.com

© 2017 Paragon BioTeck, Inc. All Rights Reserved.

Privacy Policy | Return Policy | Terms of Use | Social Media Guidelines